Jane Street’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 6423 |
|
|
2025
Q1 | – | Sell |
-352,855
| Closed | -$2.39M | – | 6421 |
|
|
2024
Q4 | $2.39M | Buy |
352,855
+114,822
| +48% | +$776K | ﹤0.01% | 1894 |
|
|
2024
Q3 | $1.57M | Sell |
238,033
-337,200
| -59% | -$2.22M | ﹤0.01% | 2754 |
|
|
2024
Q2 | $4.31M | Buy |
575,233
+363,283
| +171% | +$2.72M | ﹤0.01% | 1844 |
|
|
2024
Q1 | $2.11M | Sell |
211,950
-130,711
| -38% | -$1.3M | ﹤0.01% | 2257 |
|
|
2023
Q4 | $3.38M | Buy |
342,661
+307,097
| +864% | +$3.03M | ﹤0.01% | 1887 |
|
|
2023
Q3 | $272K | Sell |
35,564
-69,938
| -66% | -$535K | ﹤0.01% | 4146 |
|
|
2023
Q2 | $788K | Buy |
105,502
+10,531
| +11% | +$78.7K | ﹤0.01% | 3312 |
|
|
2023
Q1 | $633K | Buy |
94,971
+67,878
| +251% | +$453K | ﹤0.01% | 3402 |
|
|
2022
Q4 | $209K | Sell |
27,093
-7,431
| -22% | -$57.3K | ﹤0.01% | 4353 |
|
|
2022
Q3 | $367K | Buy |
34,524
+10,681
| +45% | +$114K | ﹤0.01% | 3966 |
|
|
2022
Q2 | $194K | Buy |
23,843
+9,876
| +71% | +$80.4K | ﹤0.01% | 4466 |
|
|
2022
Q1 | $100K | Sell |
13,967
-4,098
| -23% | -$29.3K | ﹤0.01% | 4977 |
|
|
2021
Q4 | $309K | Buy |
+18,065
| New | +$309K | ﹤0.01% | 3976 |
|